The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions

Recently, the morbidity and mortality of pancreatic cancer have been increasing year by year. Because of its deep anatomical location and because most presented patients often suffer from abdominal pain or jaundice, it is difficult to diagnose pancreatic cancer at an early stage, leading to late cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jindan, Fu, Chaojiang, Zhao, Sheng, Pu, Yongzhu, Yang, Fake, Zeng, Shuguang, Yang, Conghui, Gao, Hongqiang, Chen, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175752/
https://www.ncbi.nlm.nih.gov/pubmed/37188192
http://dx.doi.org/10.3389/fonc.2023.920896
_version_ 1785040279237033984
author Li, Jindan
Fu, Chaojiang
Zhao, Sheng
Pu, Yongzhu
Yang, Fake
Zeng, Shuguang
Yang, Conghui
Gao, Hongqiang
Chen, Long
author_facet Li, Jindan
Fu, Chaojiang
Zhao, Sheng
Pu, Yongzhu
Yang, Fake
Zeng, Shuguang
Yang, Conghui
Gao, Hongqiang
Chen, Long
author_sort Li, Jindan
collection PubMed
description Recently, the morbidity and mortality of pancreatic cancer have been increasing year by year. Because of its deep anatomical location and because most presented patients often suffer from abdominal pain or jaundice, it is difficult to diagnose pancreatic cancer at an early stage, leading to late clinical stage and poor prognosis. integrated positron emission tomography/magnetic resonance imaging (PET/MRI) fusion imaging not only has the characteristics of high resolution and multi-parameter imaging of MRI, but also combines the high sensitivity and the semi-quantitative characteristics of PET. In addition, the continuous development of novel MRI imaging and PET imaging biomarkers provide a unique and precise research direction for future pancreatic cancer research. This review summarizes the value of PET/MRI in the diagnosis, staging, efficacy monitoring, and prognosis evaluation of pancreatic cancer, and prognosis for developing emerging imaging agents and artificial intelligence radiomics in pancreatic cancer.
format Online
Article
Text
id pubmed-10175752
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101757522023-05-13 The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions Li, Jindan Fu, Chaojiang Zhao, Sheng Pu, Yongzhu Yang, Fake Zeng, Shuguang Yang, Conghui Gao, Hongqiang Chen, Long Front Oncol Oncology Recently, the morbidity and mortality of pancreatic cancer have been increasing year by year. Because of its deep anatomical location and because most presented patients often suffer from abdominal pain or jaundice, it is difficult to diagnose pancreatic cancer at an early stage, leading to late clinical stage and poor prognosis. integrated positron emission tomography/magnetic resonance imaging (PET/MRI) fusion imaging not only has the characteristics of high resolution and multi-parameter imaging of MRI, but also combines the high sensitivity and the semi-quantitative characteristics of PET. In addition, the continuous development of novel MRI imaging and PET imaging biomarkers provide a unique and precise research direction for future pancreatic cancer research. This review summarizes the value of PET/MRI in the diagnosis, staging, efficacy monitoring, and prognosis evaluation of pancreatic cancer, and prognosis for developing emerging imaging agents and artificial intelligence radiomics in pancreatic cancer. Frontiers Media S.A. 2023-04-28 /pmc/articles/PMC10175752/ /pubmed/37188192 http://dx.doi.org/10.3389/fonc.2023.920896 Text en Copyright © 2023 Li, Fu, Zhao, Pu, Yang, Zeng, Yang, Gao and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Jindan
Fu, Chaojiang
Zhao, Sheng
Pu, Yongzhu
Yang, Fake
Zeng, Shuguang
Yang, Conghui
Gao, Hongqiang
Chen, Long
The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
title The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
title_full The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
title_fullStr The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
title_full_unstemmed The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
title_short The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
title_sort progress of pet/mri in clinical management of patients with pancreatic malignant lesions
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175752/
https://www.ncbi.nlm.nih.gov/pubmed/37188192
http://dx.doi.org/10.3389/fonc.2023.920896
work_keys_str_mv AT lijindan theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT fuchaojiang theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT zhaosheng theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT puyongzhu theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT yangfake theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT zengshuguang theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT yangconghui theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT gaohongqiang theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT chenlong theprogressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT lijindan progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT fuchaojiang progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT zhaosheng progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT puyongzhu progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT yangfake progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT zengshuguang progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT yangconghui progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT gaohongqiang progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions
AT chenlong progressofpetmriinclinicalmanagementofpatientswithpancreaticmalignantlesions

Ejemplares similares